http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008109929-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
| filingDate | 2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008109929-A |
| titleOfInvention | METHOD FOR TREATING OR PREVENTING PHYSIOLOGICAL AND / OR PATHYPHYSIOLOGICAL CONDITIONS MEDIATED BY RECEPTORS STIMULATING GROWTH HORMONE SECRETION, TRIAZOLI-ITSOPHYZEMIUM FILM |
| abstract | 1. The use of a method for the treatment or prevention of physiological and/or pathophysiological conditions mediated by receptors that stimulate the secretion of growth hormone (SSHR receptors) and selected from the group including short-term, medium-term and/or long-term regulation of energy balance; short-term, medium-term and/or long-term regulation (stimulation and/or inhibition) of food intake; adipogenesis, obesity and/or obesity; increase and/or decrease in body weight in mammals, in which the compound covered by the general structural formula (I) is used in the preparation of a medicinal product: ! ! where ! R1 and R2 are independently selected from the group consisting of a hydrogen atom, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, alkylsulfonyl, arylsulfonyl, arylalkylsulfonyl, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, heterocyclyl and/or heterocyclylalkyl may contain up to 3 substituents independently selected from the group consisting of halogen, -F, -Cl, -Br, -l1 -N3, -CN, -NR7R8, -OH, -NO2, alkyl, aryl, arylalkyl, -O-alkyl, -O-aryl, -O-arylalkyl; and is preferably selected from the group consisting of alkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl optionally having up to 3 substituents independently selected from the group consisting of halogen, -F, -Cl, -Br, -I, -N3, -CN, - NR7R8, -OH, -NO2, alkyl, aryl, arylalkyl, -O-alkyl, -O-aryl, -O-arylalkyl; ! one of the radicals R3 and R4 represents a hydrogen atom, and the other radical is selected from the group consisting of a hydrogen atom, alkyl, aryl, heteroaryl, arylalkyl, heteroaryl. |
| priorityDate | 2005-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 554.